Takeabreak2021-01-27 08:38
$Affimed(AFMD)$ 顺势下滑,机不可失。来到了增发价。double down 。PT 天知道,只知道extremely undervalued $Bicycle治疗(BCYC)$ $G1治疗(GTHX)$查看全文
佐治亚理工博后2020-12-10 17:12
$G1治疗(GTHX)$ 公司的发展开始进入快车道,昨天最新一批的临床数据公布,trilaciclib治疗乳腺癌的二期结果很好,将进入三期临床;到了明年2月份,FDA将会批准trilaciclib治疗小细胞肺癌;今年第四季度trilaciclib也将开展结直肠癌的三期临床,296人的自愿者募集工作基本完成。目前一个适应症即将...查看全文
$G1 Therapeutics(GTHX)$ PRE 14A Other preliminary proxy statements Accession Number: 0001193125-24-094655 Act: 34 Size: 3 MB 网页链接
$G1 Therapeutics(GTHX)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-003017 Act: 33 Size: 4 KB 网页链接
$G1 Therapeutics(GTHX)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001628280-24-012736 Act: 34 Size: 286 KB 网页链接
$G1 Therapeutics(GTHX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-002948 Size: 9 KB 网页链接
$G1 Therapeutics(GTHX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-002949 Size: 9 KB 网页链接
$G1 Therapeutics(GTHX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-002952 Size: 5 KB 网页链接
$G1 Therapeutics(GTHX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-002880 Size: 9 KB 网页链接
$G1 Therapeutics(GTHX)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001628280-24-007601 Act: 34 Size: 9 MB 网页链接
$G1 Therapeutics(GTHX)$ 8-K Current report, item 2.02 Accession Number: 0001628280-24-007378 Act: 34 Size: 1 MB 网页链接
$G1 Therapeutics(GTHX)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-24-041509 Act: 34 Size: 49 KB 网页链接